Back to Search Start Over

Intraarterial Nimodipine Versus Induced Hypertension for Delayed Cerebral Ischemia: A Modified Treatment Protocol

Authors :
Weiss, Miriam
Albanna, Walid
Conzen-Dilger, Catharina
Kastenholz, Nick
Seyfried, Katharina
Ridwan, Hani
Wiesmann, Martin
Veldeman, Michael
Schmidt, Tobias Philip
Megjhani, Murad
Schulze-Steinen, Henna
Clusmann, Hans
Aries, Marinus Johannes Hermanus
Park, Soojin
Schubert, Gerrit Alexander
Weiss, Miriam
Albanna, Walid
Conzen-Dilger, Catharina
Kastenholz, Nick
Seyfried, Katharina
Ridwan, Hani
Wiesmann, Martin
Veldeman, Michael
Schmidt, Tobias Philip
Megjhani, Murad
Schulze-Steinen, Henna
Clusmann, Hans
Aries, Marinus Johannes Hermanus
Park, Soojin
Schubert, Gerrit Alexander
Source :
Stroke vol.53 (2022) nr.8 p.2607-2616 [ISSN 0039-2499]
Publication Year :
2022

Abstract

BACKGROUND: Rescue treatment for delayed cerebral ischemia (DCI) after subarachnoid hemorrhage can include induced hypertension (iHTN) and, in refractory cases, endovascular approaches, of which selective, continuous intraarterial nimodipine (IAN) is one variant. The combination of iHTN and IAN can dramatically increase vasopressor demand. In case of unsustainable doses, iHTN is often prioritized over IAN. However, evidence in this regard is largely lacking. We investigated the effects of a classical (iHTN+IAN) and modified (IANonly) treatment protocol for refractory DCI in an observational study.METHODS: Rescue treatment for DCI was initiated with iHTN (target >180 mm Hg systolic) and escalated to IAN in refractory cases. Until July 2018, both iHTN and IAN were offered in cases refractory to iHTN alone. After protocol modification, iHTN target was preemptively lowered to >120 mm Hg when IAN was initiated (IANonly). Primary outcome was noradrenaline demand. Secondary outcomes included noradrenaline-associated complications, brain tissue oxygenation, DCI-related infarction and favorable 6-month outcome (Glasgow Outcome Scale 4-5).RESULTS: N=29 and n=20 patients were treated according to the classical and modified protocol, respectively. Protocol modification resulted in a significant reduction of noradrenaline demand (iHTN+IAN 0.70±0.54 µg/kg per minute and IANonly 0.26±0.20 µg/kg per minute, P<0.0001) and minor complications (15.0% versus 48.3%, unadjusted odds ratio, 0.19 [95% CI, 0.05-0.79]; P<0.05) with comparable rates of major complications (20.0% versus 20.7%, odds ratio, 0.96 [0.23-3.95]; P=0.95). Incidence of DCI-related infarction (45.0% versus 41.1%, odds ratio, 1.16 [0.37-3.66]; P=0.80) and favorable clinical outcome (55.6% versus 40.0%, odds ratio, 1.88 [0.55-6.39]; P=0.32) were similar. Brain tissue oxygenation was significantly higher with IANonly (26.6±12.8, 39.6±15.4 mm Hg; P<0.01).CONCLUSIONS: Assuming the pote

Details

Database :
OAIster
Journal :
Stroke vol.53 (2022) nr.8 p.2607-2616 [ISSN 0039-2499]
Notes :
DOI: 10.1161/strokeaha.121.038216, English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1363325462
Document Type :
Electronic Resource